UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 31, 2015 5:30 P.M.
Form:
S-1
CIK:
0001059784
Company Name:
GENEREX BIOTECHNOLOGY CORP
File Number:
333-205724